Literature DB >> 12621025

Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

Max Dolder1, Bernd Walzel, Oliver Speer, Uwe Schlattner, Theo Wallimann.   

Abstract

Mitochondria from transgenic mice, expressing enzymatically active mitochondrial creatine kinase in liver, were analyzed for opening of the permeability transition pore in the absence and presence of creatine kinase substrates but with no external adenine nucleotides added. In mitochondria from these transgenic mice, cyclosporin A-inhibited pore opening was delayed by creatine or cyclocreatine but not by beta-guanidinopropionic acid. This observation correlated with the ability of these substrates to stimulate state 3 respiration in the presence of extramitochondrial ATP. The dependence of transition pore opening on calcium and magnesium concentration was studied in the presence and absence of creatine. If mitochondrial creatine kinase activity decreased (i.e. by omitting magnesium from the medium), protection of permeability transition pore opening by creatine or cyclocreatine was no longer seen. Likewise, when creatine kinase was added externally to liver mitochondria from wild-type mice that do not express mitochondrial creatine kinase in liver, no protective effect on pore opening by creatine and its analog was observed. All these findings indicate that mitochondrial creatine kinase activity located within the intermembrane and intercristae space, in conjunction with its tight functional coupling to oxidative phosphorylation, via the adenine nucleotide translocase, can modulate mitochondrial permeability transition in the presence of creatine. These results are of relevance for the design of creatine analogs for cell protection as potential adjuvant therapeutic tools against neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621025     DOI: 10.1074/jbc.M208705200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Analysis of functional coupling: mitochondrial creatine kinase and adenine nucleotide translocase.

Authors:  Marko Vendelin; Maris Lemba; Valdur A Saks
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 3.  Cardiac system bioenergetics: metabolic basis of the Frank-Starling law.

Authors:  Valdur Saks; Petras Dzeja; Uwe Schlattner; Marko Vendelin; Andre Terzic; Theo Wallimann
Journal:  J Physiol       Date:  2006-01-12       Impact factor: 5.182

4.  Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.

Authors:  Holger Lenz; Melanie Schmidt; Vivienne Welge; Thomas Kueper; Uwe Schlattner; Theo Wallimann; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Staeb; Thomas Blatt
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

Review 5.  Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Authors:  Peter J Adhihetty; M Flint Beal
Journal:  Neuromolecular Med       Date:  2008-11-13       Impact factor: 3.843

6.  Intracellular energetic units in healthy and diseased hearts.

Authors:  Enn K Seppet; Margus Eimre; Tiia Anmann; Evelin Seppet; Nadezhda Peet; Tuuli Käämbre; Kalju Paju; Andres Piirsoo; Andrei V Kuznetsov; Marko Vendelin; Frank N Gellerich; Stephan Zierz; Valdur A Saks
Journal:  Exp Clin Cardiol       Date:  2005

7.  Mitochondrial therapies for Parkinson's disease.

Authors:  Bobby Thomas; M Flint Beal
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 8.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

Review 9.  Energy metabolism in heart failure.

Authors:  Renée Ventura-Clapier; Anne Garnier; Vladimir Veksler
Journal:  J Physiol       Date:  2003-12-05       Impact factor: 5.182

Review 10.  Application of the principles of systems biology and Wiener's cybernetics for analysis of regulation of energy fluxes in muscle cells in vivo.

Authors:  Rita Guzun; Valdur Saks
Journal:  Int J Mol Sci       Date:  2010-03-08       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.